Unfractionated Heparin IV

DRUG2 trials

Sponsors

The TIMI Study Group, Ain Shams University

Conditions

Arterial ThrombosisCOVID-19Pulmonary Embolism Subacute MassiveThrombolytic TherapyVenous Thromboembolism

Phase 4

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

CompletedNCT04409834

The TIMI Study GroupArterial Thrombosis, COVID-19, Venous Thromboembolism

Start: 2020-08-05End: 2022-03-10Updated: 2024-01-19

Unknown Phase

Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk

CompletedNCT07374978

Ain Shams UniversityPulmonary Embolism Subacute Massive, Thrombolytic Therapy

Start: 2023-07-01End: 2025-07-01Updated: 2026-01-29

Related Papers

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Circulation2022-08-2981 citations

Platelet Reactivity and Coagulation Markers in Patients with COVID-19

Advances in Therapy2021-06-0430 citations